Last Updated 20 October 2021.
4 Vaccines Approved for Use in Russian Federation
-
FBRI
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
Approval Source: cnbc.com
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 18 countries
4 trials in 2 countries
Approval Source: rdif.ru
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 72 countries
22 trials in 2 countries
Approval Source: theguardian.com
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
Approval Source: grls.rosminzdrav.ru
8 Vaccines in Clinical Trials in Russian Federation
-
FBRI
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 18 countries
4 trials in 2 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 72 countries
22 trials in 2 countries
-
Biocad
BCD-250- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
11 trials in 6 countries
-
Institute of Vaccines and Medical Biologicals
COVIVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 124 countries
45 trials in 23 countries
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country